Outcome of patients older than 85 years hospitalized in a neurology unit.


Journal

Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 19 05 2023
accepted: 02 06 2023
medline: 24 7 2023
pubmed: 18 6 2023
entrez: 18 6 2023
Statut: ppublish

Résumé

Advanced age is a major determinant of mortality and poor outcome at any level. In hospitalized patients, advanced age is a major issue in terms of prognosis, resource use, and therapeutic choices. We aimed at assessing the 1 year outcome of elderly patients admitted to a neurology unit for various acute conditions. Consecutive patients admitted to a neurology unit were enrolled and followed-up at 3, 6, and 12 months with structured phone interviews gathering information about mortality, disability, hospital readmissions, and place of residency. Inclusion criteria were age ≥ 85 years, availability of written consent and phone contact; no exclusion criteria were applied. Over a period of 16 months, 131 patients (88.8 ± 3.3, 92 females, 39 males) were admitted. The pre-hospitalization modified Rankin Scale (mRS) median (IQR) score, obtainable in 125 patients, was 2 (0, 3) and > 3 in 28/125 (22.4%) patients. Fifty-eight (46.8%) patients had pre-existing dementia (this information was missing for one patient). Eleven patients died during hospitalization. Of the 120 discharged patients, 60 (50%) were alive at 12 months, 41 died during follow-up (34.2%), and 19 (15.8%) were lost. At 12 months, out of the 60 alive patients, 29 (48.3%) had a mRS > 3. We did not detect predictors of 12-month survival. Predictors of 12-month worsening of functional status were pre-hospitalization mRS, pre-existing cognitive impairment, and male sex. One-year mortality of elderly patients admitted to a neurology unit is extremely high. After one year, less than one fourth of elderly patients hospitalised for an acute neurological disease are left with only no-to-moderate disability.

Sections du résumé

BACKGROUND BACKGROUND
Advanced age is a major determinant of mortality and poor outcome at any level. In hospitalized patients, advanced age is a major issue in terms of prognosis, resource use, and therapeutic choices.
AIMS OBJECTIVE
We aimed at assessing the 1 year outcome of elderly patients admitted to a neurology unit for various acute conditions.
METHODS METHODS
Consecutive patients admitted to a neurology unit were enrolled and followed-up at 3, 6, and 12 months with structured phone interviews gathering information about mortality, disability, hospital readmissions, and place of residency. Inclusion criteria were age ≥ 85 years, availability of written consent and phone contact; no exclusion criteria were applied.
RESULTS RESULTS
Over a period of 16 months, 131 patients (88.8 ± 3.3, 92 females, 39 males) were admitted. The pre-hospitalization modified Rankin Scale (mRS) median (IQR) score, obtainable in 125 patients, was 2 (0, 3) and > 3 in 28/125 (22.4%) patients. Fifty-eight (46.8%) patients had pre-existing dementia (this information was missing for one patient). Eleven patients died during hospitalization. Of the 120 discharged patients, 60 (50%) were alive at 12 months, 41 died during follow-up (34.2%), and 19 (15.8%) were lost. At 12 months, out of the 60 alive patients, 29 (48.3%) had a mRS > 3. We did not detect predictors of 12-month survival. Predictors of 12-month worsening of functional status were pre-hospitalization mRS, pre-existing cognitive impairment, and male sex.
CONCLUSIONS CONCLUSIONS
One-year mortality of elderly patients admitted to a neurology unit is extremely high. After one year, less than one fourth of elderly patients hospitalised for an acute neurological disease are left with only no-to-moderate disability.

Identifiants

pubmed: 37330922
doi: 10.1007/s40520-023-02468-x
pii: 10.1007/s40520-023-02468-x
pmc: PMC10363031
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1753-1761

Informations de copyright

© 2023. The Author(s).

Références

Top Stroke Rehabil. 2018 Dec;25(8):576-583
pubmed: 30281414
Scand J Public Health. 2008 Mar;36(2):197-204
pubmed: 18519285
Scott Med J. 1957 May;2(5):200-15
pubmed: 13432835
J Am Geriatr Soc. 1968 May;16(5):622-6
pubmed: 5646906
Z Gerontol Geriatr. 2001 Oct;34(5):395-400
pubmed: 11718102
Neurology. 1993 Nov;43(11):2412-4
pubmed: 8232972
Acta Neurol Scand. 2020 Oct;142(4):377-384
pubmed: 32687600
JAMA. 2001 Jun 20;285(23):2987-94
pubmed: 11410097
Exp Gerontol. 2017 Mar;89:30-40
pubmed: 28043934
Aging Clin Exp Res. 2022 Feb;34(2):409-418
pubmed: 34255297

Auteurs

Giacomo Querzola (G)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Andrea Bellomo (A)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Emilia Salvadori (E)

NEUROFARBA Department, Neuroscience Section, University of Florence, Florence, Italy.

Leonardo Pantoni (L)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy. leonardo.pantoni@unimi.it.
Neurology Unit, Luigi Sacco University Hospital, Milan, Italy. leonardo.pantoni@unimi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH